跳至主要内容
临床试验/NCT01315613
NCT01315613已完成不适用

Study of ST2-IL-33 Pathway in Acute Pancreatitis

Erasme University Hospital1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2005年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
44
试验地点
1
主要终点
Concentration of soluble ST2 in serum

研究概览

简要总结

Acute pancreatitis is characterized by an inflammatory storm which regulatory pathways are not well known. The IL-1 cytokine family is activated early during acute pancreatitis and secretion of alarmins is speculated during pancreatic necrosis. IL-33 is a member of the IL-1 family, it can act as an alarmin and its receptor, ST2, is known to sequester MyD88 which might regulate the acute pancreatitis inflammatory storm. The aim of this study is to investigate ST2 pathway in human acute pancreatitis and in murine experimental models of acute pancreatitis.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Time to take blood sample less than 24h after the onset of symptoms of AP
  • Two of the following: typical pain, amylase and lipase concentrations more than 3x the upper normal limit, compatible modifications on imaging techniques

排除标准

  • Chronic pancreatitis

结局指标

主要结局

Concentration of soluble ST2 in serum

时间窗: Within 30 days after onset of acute pancreatitis

Concentration of soluble ST2 will be assessed in the serum of patient with an episode of acute pancreatitis, on the day of admission to the hospital as well as 24h, 48h, 7 days and 30 days later.

次要结局

未报告次要终点

研究者

发起方
Erasme University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验